Targeting the Wnt signaling pathway in colorectal cancer

Bibliography

• Kato H, Sobue T, Katanoda K, et al. Editorial Board of the Cancer Statistics in Japan. Cancer statistics in Japan 2007. Foundation for Promotion of Cancer Research (FPCF); Tokyo: 2007
   Google Scholar
• Pham NM, Mizoue T, Tanaka K, et al. Meat consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2014;44:641-50
   PubMed Web of Science ®Google Scholar
• Isomura K, Kono S, Moore MA, et al. Physical activity and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci 2006;97:1099-104
   PubMed Web of Science ®Google Scholar
• Okuno K. Surgical treatment for digestive cancer. Current issues - colon cancer. Dig Surg 2007;24:108-14
   PubMed Web of Science ®Google Scholar
• Pasetto LM, Jirillo A, Iadicicco G, et al. FOLFOX versus FOLFIRI: a comparison of regimens in the treatment of colorectal cancer metastases. Anticancer Res 2005;25:563-76
   PubMed Web of Science ®Google Scholar
• Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 2015;20:207-39
   PubMed Web of Science ®Google Scholar
• Koutras AK, Starakis I, Kyriakopoulou U, et al. Targeted therapy in colorectal cancer: current status and future challenges. Curr Med Chem 2011;18:1599-612
   PubMed Web of Science ®Google Scholar
• Omura K. Advances in chemotherapy against advanced or metastatic colorectal cancer. Digestion 2008;77(Suppl 1):13-22
   PubMed Web of Science ®Google Scholar
• Grothey A, Van Cutsem E, Sobrero A, et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 2013;381:303-12
   PubMed Web of Science ®Google Scholar
• Li Y, Rogoff HA, Keates S, et al. Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proc Natl Acad Sci USA 2015;112:1839-44
   PubMed Web of Science ®Google Scholar
• Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70
   PubMed Web of Science ®Google Scholar
• Sparks AB, Morin PJ, Vogelstein B, et al. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58:1130-4
   PubMed Web of Science ®Google Scholar
• Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253:665-9
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5
   PubMed Web of Science ®Google Scholar
• Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997;275:1787-90
   PubMed Web of Science ®Google Scholar
• Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7
   PubMed Web of Science ®Google Scholar
• Dow LE, O’Rourke KP, Simon J, et al. Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell 2015;161:1539-52
   PubMed Web of Science ®Google Scholar
• Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012;149:1192-205
   PubMed Web of Science ®Google Scholar
• Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-51
   PubMed Web of Science ®Google Scholar
• Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-7
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90
   PubMed Web of Science ®Google Scholar
• Hayashida Y, Honda K, Idogawa M, et al. E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res 2005;65:8836-45
   PubMed Web of Science ®Google Scholar
• Yamada T, Takaoka AS, Naishiro Y, et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res 2000;60:4761-6
   PubMed Web of Science ®Google Scholar
• Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998;19:379-83
   PubMed Web of Science ®Google Scholar
• van Es JH, Haegebarth A, Kujala P, et al. A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. Mol Cell Biol 2012;32:1918-27
   PubMed Web of Science ®Google Scholar
• Barker N, Ridgway RA, van Es JH, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009;457:608-11
   PubMed Web of Science ®Google Scholar
• Koo BK, Clevers H. Stem cells marked by the R-spondin receptor LGR5. Gastroenterology 2014;147:289-302
   PubMed Web of Science ®Google Scholar
• Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007;19:150-8
   PubMed Web of Science ®Google Scholar
• Lin L, Liu A, Peng Z, et al. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res 2011;71:7226-37
   PubMed Web of Science ®Google Scholar
• Wielenga VJ, Smits R, Korinek V, et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999;154:515-23
   PubMed Web of Science ®Google Scholar
• O’Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-10
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Sakamoto M, Fujii G, et al. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations. Hepatology 2003;37:528-33
   PubMed Web of Science ®Google Scholar
• Sansom OJ, Reed KR, Hayes AJ, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 2004;18:1385-90
   PubMed Web of Science ®Google Scholar
• Yamada T, Mori Y, Hayashi R, et al. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. Cancer Res 2003;63:895-901
   PubMed Web of Science ®Google Scholar
• Kim PJ, Plescia J, Clevers H, et al. Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003;362:205-9
   PubMed Web of Science ®Google Scholar
• Tetsu O, McCormick F. Beta-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6
   PubMed Web of Science ®Google Scholar
• He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12
   PubMed Web of Science ®Google Scholar
• Sansom OJ, Meniel VS, Muncan V, et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007;446:676-9
   PubMed Web of Science ®Google Scholar
• Chen B, Dodge ME, Tang W, et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 2009;5:100-7
   PubMed Web of Science ®Google Scholar
• Liu J, Pan S, Hsieh MH, et al. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci USA 2013;110:20224-9
   PubMed Web of Science ®Google Scholar
• Gurney A, Axelrod F, Bond CJ, et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci USA 2012;109:11717-22
   PubMed Web of Science ®Google Scholar
• Le PN, McDermott JD, Jimeno A. Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28. Pharmacol Ther 2015;146:1-11
   PubMed Web of Science ®Google Scholar
• Huang SM, Mishina YM, Liu S, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 2009;461:614-20
   PubMed Web of Science ®Google Scholar
• Waaler J, Machon O, Tumova L, et al. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. Cancer Res 2012;72:2822-32
   PubMed Web of Science ®Google Scholar
• Li J, Sutter C, Parker DS, et al. CBP/p300 are bimodal regulators of Wnt signaling. EMBO J 2007;26:2284-94
   PubMed Web of Science ®Google Scholar
• Emami KH, Nguyen C, Ma H, et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci USA 2004;101:12682-7
   PubMed Web of Science ®Google Scholar
• Lenz HJ, Kahn M. Safely targeting cancer stem cells via selective catenin coactivator antagonism. Cancer Sci 2014;105:1087-92
   PubMed Web of Science ®Google Scholar
• Shitashige M, Satow R, Honda K, et al. Regulation of Wnt signaling by the nuclear pore complex. Gastroenterology 2008;134:1961-71.1971e1-4
   PubMed Web of Science ®Google Scholar
• Mahmoudi T, Li VS, Ng SS, et al. The kinase TNIK is an essential activator of Wnt target genes. EMBO J 2009;28:3329-40
   PubMed Web of Science ®Google Scholar
• Shitashige M, Satow R, Jigami T, et al. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth. Cancer Res 2010;70:5024-33
   PubMed Web of Science ®Google Scholar
• Yamada T, Shitashige M, Hirohashi S. Screening method for anticancer drug. WO2009104413; 2008
   Google Scholar
• Kahn M. Can we safely target the WNT pathway? Nat Rev Drug Discov 2014;13:513-32
   PubMed Web of Science ®Google Scholar
• Satow R, Shitashige M, Jigami T, et al. Traf2- and Nck-interacting kinase is essential for canonical Wnt signaling in Xenopus axis formation. J Biol Chem 2010;285:26289-94
   PubMed Web of Science ®Google Scholar
• Coba MP, Komiyama NH, Nithianantharajah J, et al. TNiK is required for postsynaptic and nuclear signaling pathways and cognitive function. J Neurosci 2012;32:13987-99
   PubMed Web of Science ®Google Scholar
• Gui J, Yang B, Wu J, et al. Enormous influence of TNIK knockdown on intracellular signals and cell survival. Hum Cell 2011;24:121-6
   PubMed Web of Science ®Google Scholar
• Fu CA, Shen M, Huang BC, et al. TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton. J Biol Chem 1999;274:30729-37
   PubMed Web of Science ®Google Scholar
• Shkoda A, Town JA, Griese J, et al. The germinal center kinase TNIK is required for canonical NF-kappaB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor. PLoS Biol 2012;10:e1001376
   PubMed Web of Science ®Google Scholar
• Taira K, Umikawa M, Takei K, et al. The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton. J Biol Chem 2004;279:49488-96
   PubMed Web of Science ®Google Scholar
• Li GH, Arora PD, Chen Y, et al. Multifunctional roles of gelsolin in health and diseases. Med Res Rev 2012;32:999-1025
   PubMed Web of Science ®Google Scholar
• Jiao X, Hooper SD, Djureinovic T, et al. Gene rearrangements in hormone receptor negative breast cancers revealed by mate pair sequencing. BMC Genomics 2013;14:165
   PubMed Web of Science ®Google Scholar
• Yu DH, Zhang X, Wang H, et al. The essential role of TNIK gene amplification in gastric cancer growth. Oncogenesis 2014;2:e89
   Google Scholar
• Ho KK, Parnell KM, Yuan Y, et al. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors. Bioorg Med Chem Lett 2013;23:569-73
   PubMed Web of Science ®Google Scholar
• Yamada T, Shitashige M, Yokota K, et al. Tnik inhibitor and the use. WO2010064111; 2008
   Google Scholar
• Uno Y, Moriyama H, Kashimoto S, et al. Targeting Wnt signaling: Discovery and characterization of novel thiazole-based Traf2- and NCK-interacting kinase (TNIK) inhibitors. Mol Cancer Ther 2013;12:B265
   Google Scholar
• Krishnamurty R, Brigham JL, Leonard SE, et al. Active site profiling reveals coupling between domains in SRC-family kinases. Nat Chem Biol 2013;9:43-50
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007;3:542-5
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8
   PubMed Web of Science ®Google Scholar
• Drabsch Y, Ten Dijke P. TGF-beta signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev 2012;31:553-68
   PubMed Web of Science ®Google Scholar
• Fuxe J, Vincent T, Garcia de Herreros A. Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010;9:2363-74
   PubMed Web of Science ®Google Scholar
• Akhmetshina A, Palumbo K, Dees C, et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 2012;3:735
   PubMed Web of Science ®Google Scholar
• Kim J, Moon SH, Kim BT, et al.A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-beta1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells. PLoS One 2014;9:e110180
   Google Scholar